Nora Sandorfi, MD
Rheumatology
Accepting new patients
Sees patients age 18 and up
Penn Rheumatology Perelman
View 1 additional location
Schedule onlineCall 215-662-2454
Penn Medicine Provider

About me

  • Professor of Clinical Medicine (Rheumatology)

Dr. Nora Sandorfi, MD, is a Professor of Clinical Medicine in the Division of Rheumatology at the Perelman School of Medicine, University of Pennsylvania, with a special focus on Systemic Sclerosis (scleroderma) and Sjögren’s syndrome. She completed her medical training at Semmelweis University in Budapest, followed by residencies and fellowships in Philadelphia, including at Thomas Jefferson University Hospital. Over the past two decades, Dr. Sandorfi has served as Principal Investigator on numerous clinical trials and mentored rheumatology fellows in the scleroderma specialty clinic. Her commitment to patient education is also notable—she regularly participates in outreach and educational events aimed at those living with scleroderma. Dr. Sandorfi is highly regarded for her deep clinical expertise, empathetic communication, and dedication to patient well-being. In her spare time, Dr. Sandorfi is an avid bicyclist.

Education and training

  • Medical School: Semmelweis University, Medical School
  • Fellowship: Hahnemann University Hospital
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating

1412 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
she cares about her patients
January 2026
thorough
January 2026
she is very thorough
January 2026
she is a known specialist

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Sandorfi is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Sandorfi, N, Shea L, Keenan A, Adamson E, Zazzetti F, Chakravarty S, Gotshall D, Gandhi J, Ranjan S, Akpek E A Systematic Literature Review on the Economic Burden of Sjögren’s Disease , ACR Convergence Annual Meeting, Abstract Number: 1376: 2025

Johr CR, George MD, Bunya VY, Sandorfi N, Massaro-Giordano M, Vivino FB Diagnostic Utility of Testing for Novel Murine Autoantibodies for Sjögren's Disease in the Rheumatology Outpatient Setting , Arthritis Care Res (Hoboken): 2025

Akpek E, Adamson E, Shea L, Zazzetti F, Chakravarty S, Ranjan S, Potluri R, Keenan A Humanistic Burden of Sjögren’s Disease: A Systematic Review of Treatment Efficacy on Health-Related Quality-of-Life , ACR Convergence Annual Meeting, Abstract Number: 1377: 2025

Lee, S, Johr C, Sandorfi N, Dhanaliwala A, DiRenzo D Implementation of Salivary Gland Ultrasound by General Radiology can Improve Detection of Glandular Inflammation in Patients with Sicca , ACR Convergence Annual M: 2025,Abstract Number: 0520

Mehmetoglu E, Mummadisetty A, Chatzittofis A, Parperis K, Sandorfi N, Derk CT. Rebuttal for letter to the editor from Miss Nassar and Dr Thombs regarding: "A systematic review of prevalence and predictors of depression in systemic sclerosis based on the CES-D, BDI, and PHQ-9 self-assessment questionnaires". , Clin Rheumatol, 8: 2025,3387

Luo Y, Assassi S, Mayes MD, Frech TM, Steen VD, Richardson C, Chung L, Sandorfi N, VanBuren JM, Harding M, Alvey JS, Skaug B, McMahan ZH, Lakin KS, Zahn C, Bracken SJ, Lebiedz-Odrobina DJ, Molitor JA, Evnin LB, Moore DF, Shah A, Castelino FV, Volkmann ER, Hant FN, Makol A, Shah AA, Hummers LK, Gordon JK, Khanna D, Bernstein EJ Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. , Ann Am Thorac Soc., 8: 2025,1265-1269

Mehmetoglu E, Mummadisetty A, Chatzittofis A, Parperis K, Sandorfi N, Derk CT A systematic review of prevalence and predictors of depression in systemic sclerosis based on the CES-D, BDI, and PHQ- 9 self-assessment questionnaires. . 2025 Jun;44(6):2327-2341. , Clin Rheumatol, 6: 2025,2327-2341

Hanif I, Assassi S, Mayes MD, McMahan ZH, Zhang M, Charles J, VanBuren JM, Alvey JS, Ghaffari K, Bernstein EJ, Castelino FV, Chung L, Evnin L, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Steen VD, Volkmann ER, Zahn C, Skaug B. Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts , Arthritis Rheumatol: 2025,19:10.1002/art.43237

Hajnoczky N, Levin LS, Sandorfi N, Derk CT Long-term outcomes of vascular grafting of medium-sized vessels of wrist and hand in systemic sclerosis patients with medication refractory Raynaud's. , J.Scleroderma Relat Disord: 2025

Yu JM, VanBuren JM, Child A, Alvey JS, Mandl LA, Pinheiro LC, Assassi S, Bernstein EJ, Castelino FV, Chung L, Evnin L, Frech TM, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Gordon JK. Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis. , J Rheumatol., 3: 2025,263-269